Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

Yahoo FinanceMay 1 22:01

Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Mereo Biopharma Group Plc (MREO) and Arcus Biosciences (RCUS)

TipRanksMay 1 18:21

Promising Outlook for Arcus Biosciences Anchored by Strong Clinical Trials and Strategic Market Positioning

TipRanksMay 1 18:20

Arcus Biosciences to Present New Data From Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting

Updated data from EDGE-Gastric evaluating domvanalimab plus zimberelimab and chemotherapy in upper gastrointestinal (GI) cancers will be presented in a special ASCO plenary series rapid abstract update session by

BusinesswireApr 25 04:00

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update

Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will

BusinesswireApr 24 04:05

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Arcus Biosciences (RCUS)

TipRanksApr 12 18:50